As of Aug 18
| -0.15 / -1.36%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 25.50, with a high estimate of 30.00 and a low estimate of 22.00. The median estimate represents a +135.02% increase from the last price of 10.85.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.